Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Total 13F shares
-
10,354,516
-
Share change
-
+1,174,184
-
Total reported value
-
$219,827,000
-
Price per share
-
$21.23
-
Number of holders
-
33
-
Value change
-
+$23,516,053
-
Number of buys
-
14
-
Number of sells
-
33
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2017
As of 31 Dec 2017,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,354,516 shares.
The largest 10 holders included
FMR LLC, GILDER GAGNON HOWE & CO LLC, Myriad Asset Management Ltd., ORBIMED ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Segantii Capital Management Ltd, Cormorant Asset Management, LLC, Vivo Capital, LLC, Rock Springs Capital Management LP, and Marshall Wace North America L.P..
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.